Alpha 2.0
Login Register
» Authors » Chisato Nishida

Chisato Nishida

Explore the profile of Chisato Nishida including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 15
Followers 0
Related Specialties
Cardiology & Vascular Diseases
General Medicine
Biomedical Engineering
Top 10 Co-Authors
Hirotaka Numaguchi
Masayoshi Shirakawa
Hiromi Rakugi
Kazuyuki Shimada
Hiroya Yamaguchi
Kyoichi Azuma
Takuya Tsuchihashi
Kenji P Fujita
Yuki Matsumoto
Anish Mehta
Published In
Hypertens Res
Allergy Rhinol (Providence)
Clin Exp Hypertens
Clin Transl Sci
J Drug Assess
Affiliations
Soon will be listed here.
Recent Articles
1.
The Bioequivalence and Effect of Food on the Pharmacokinetics of a Fixed-Dose Combination Tablet Containing Rosuvastatin and Ezetimibe in Healthy Japanese Subjects
Nishida C, Matsumoto Y, Fujimoto K, Shirakawa M, Wrishko R, Behm M, et al.
Clin Transl Sci . 2019 Aug; 12(6):704-712. PMID: 31365188
Certain patient populations are unable to achieve the recommended low-density lipoprotein cholesterol goals with statin monotherapy alone. Such patients may benefit from concomitant therapy with ezetimibe (EZE) 10 mg added...
2.
Evaluation of Montelukast for the Treatment of Children With Japanese Cedar Pollinosis Using an Artificial Exposure Chamber (OHIO Chamber)
Hashiguchi K, Okubo K, Inoue Y, Numaguchi H, Tanaka K, Oshima N, et al.
Allergy Rhinol (Providence) . 2018 Jul; 9:2152656718783599. PMID: 30027002
Background: This study evaluated the efficacy of montelukast in reducing seasonal allergic rhinitis symptoms in Japanese children with Japanese cedar (JC) pollinosis induced in an artificial exposure chamber (OHIO Chamber)....
3.
Montelukast in the treatment of perennial allergic rhinitis in paediatric Japanese patients; an open-label clinical trial
Okubo K, Inoue Y, Numaguchi H, Tanaka K, Saito I, Oshima N, et al.
J Drug Assess . 2016 Oct; 5(1):6-14. PMID: 27785374
: This study was conducted to evaluate the safety and tolerability, and population pharmacokinetics (PPK) of montelukast as well as efficacy in the treatment of perennial allergic rhinitis (PAR) in...
4.
Add-on effect of hydrochlorothiazide 12.5 mg in Japanese subjects with essential hypertension uncontrolled with losartan 50 mg and amlodipine 5 mg
Rakugi H, Tsuchihashi T, Shimada K, Numaguchi H, Nishida C, Yamaguchi H, et al.
Hypertens Res . 2015 Feb; 38(5):329-35. PMID: 25716649
This study assessed the antihypertensive efficacy of a triple combination, fixed-dose therapy of losartan 50 mg (L50)/hydrochlorothiazide 12.5 mg (H12.5)/amlodipine 5 mg (A5) versus co-administration of L50 plus A5 (L50+A5)...
5.
Efficacy and safety of fixed-dose losartan/hydrochlorothiazide/amlodipine combination versus losartan/hydrochlorothiazide combination in Japanese patients with essential hypertension
Rakugi H, Tsuchihashi T, Shimada K, Numaguchi H, Nishida C, Yamaguchi H, et al.
Clin Exp Hypertens . 2014 Oct; 37(3):260-6. PMID: 25271811
Japanese patients with uncontrolled essential hypertension received single-blind losartan 50 mg/hydrochlorothiazide 12.5 mg (L50/H12.5) for 8 weeks. Patients whose blood pressure (BP) remained uncontrolled were randomized double-blind to fixed-dose losartan...
6.
Efficacy and safety of losartan 100 mg/hydrochlorothiazide 12.5 mg in Japanese subjects with essential hypertension: two randomized, controlled trials
Rakugi H, Tsuchihashi T, Shimada K, Numaguchi H, Nishida C, Yamaguchi H, et al.
Hypertens Res . 2014 Jul; 37(12):1042-9. PMID: 24990091
Two randomized studies were designed to assess the safety, tolerability and efficacy of losartan 100 mg (L100) plus hydrochlorothiazide 12.5 mg (H12.5) in a single fixed-dose combination. In one study,...